U.S.
Biotechnology giant Amgen, Inc. (NASDAQ:AMGN) has released positive data for its phase II study showing the efficacy and safety of its pipeline osteoporosis …
Analysts are reiterating buys on Gilead Sciences, Inc. (NASDAQ:GILD) and Amgen, Inc.
Cowen top analyst Ritu Baral chimes in on Cytokinetics, Inc. (NASDAQ:CYTK) after Amgen, Inc.
Morgan Stanley analysts were out today with commentary on healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Amgen, Inc. (NASDAQ:AMGN).
Yesterday, Jennifer asked is Valeant Pharmaceuticals the proverbial canary in the coal mine for the pharma industry? She came to the conclusion that …
To kick off biotech in 2016, analyst Joshua Schimmer of Piper Jaffray pounds the table on both Gilead Sciences, Inc. (NASDAQ:GILD) and Amgen, …
Unilife Corp (NASDAQ: UNIS) is having an incredible day in the market today after disclosing an SEC filing with regard to an exclusivity agreement with Amgen, …
Apple Inc. (NASDAQ:AAPL) was trading down 1% to about $111 in pre-market trading this morning following news that competitor Samsung is appealing the U.
Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc.